JPRN-UMIN000052759尚未招募2 期
Phase II study to examine the efficacy and safety of Awa Suzuka extracted ingredients - Phase II study of Awa Suzuka extracted ingredients
Tokushima University Graduate School0 个研究点目标入组 40 人开始时间: 2023年11月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 64years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Persons with diseases of the liver, kidney, heart, etc. Those who are taking medication for the purpose of treatment of diseases such as lifestyle-related diseases Those who have taken supplements within 1 month of the start of the study
研究者
相似试验
招募中
2 期
Evaluation of the efficacy of bioadhesive barrier-forming oral liquid gel (Episil) for prevention of oral mucositisJPRN-jRCTs062220023Takano HIdeyuki50
招募中
2 期
Phase II study of multimodality treatment for ATRTAtypical teratoid rhabdoid tumorD016543JPRN-jRCTs051200071Junichi Hara50
招募中
2 期
Phase II study of new risk classification and high-dose chemotherapy for medulloblastomaJPRN-jRCTs051200021Hara Junichi229
尚未招募
2 期
Phase II study to evaluate the efficacy and safety of mirogabalin for CIPN in patients with gastrointestinal cancer.esophageal cancer, gastric cancer, small bowel cancer, colon cancer, pancreatic cancerJPRN-UMIN000049555ational Cancer Center Hospital30
招募中
2 期
Phase II study to investigate efficacy and safety of erlotinib in patients with advanced and recurrent NSCLC with poor performance statusnon-small cell lung cancerJPRN-UMIN000003540Yamaguchi Thoracic Oncology Group(YTOG)20